Thrombectomy System Market

Thrombectomy System Market Overview (2022 to 2032)

The thrombus is removed using a thrombectomy device, which is an intracoronary catheter with a central aspiration channel. Blood clots that form in capillaries, veins, and arteries are treated with it. An artery or vein with a blood clot that is obstructing blood flow can be treated with surgical thrombectomy.

Systems for thrombectomy are created to lessen blood loss and the number of blood vessels damaged during surgery. Deep vein thrombosis, pulmonary embolism, peripheral arterial disease, and neurovascular thrombosis disorders are all treated using these devices.

What are the Major Drivers Boosting the Demand for Thrombectomy System Market?

The market's primary growth drivers include the aging population's increased prevalence of cardiovascular diseases (CVDs), technological breakthroughs in blood clot-catching medical devices, and growing public awareness of the need for early disease detection. This market is mostly driven by aging people. In future years, there will be a demographic change in which the elderly will predominate. Since the number of aging people and the prevalence of chronic diseases is both expanding globally, this has a positive impact on market growth by driving up demand for thrombectomy system.

The need to introduce cutting-edge products to the market has been brought on by the rise in ischemic stroke incidence. The market is being driven by the development and introduction of new ischemic stroke-related suction devices, clot retrievers, and aspiration catheters.

Which Region Shows Strong Growth Potential in the Thrombectomy System Market?

Thrombectomy system demand is primarily rigorous in North America because of the region's high rate of aging population and rapid technological development. A growing number of clinical trials, the increased acceptance of technologically advanced thrombectomy products by surgeons, and the availability of medical reimbursements for thrombectomy procedures in the USA are some of the factors driving the expansion of the market for thrombectomy systems in North America.

Additionally, the Asian market for thrombectomy systems is anticipated to show rapid growth in the forecast period due to a huge patient population, an expansion of public insurance in developing nations, and a surge in the acceptance of new, inventive embolization and mechanical thrombectomy devices.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Who are the Key Manufacturers in the Thrombectomy System Market?

Some of the key manufacturers operating in the thrombectomy system market are Argon Medical Devices, Inc., BD Interventional, Boston Scientific Corporation, Control Medical Technology, LLC., NexGen Medical Systems Inc., Minnetronix Medical, Medtronic, Thrombolex, Inc., AngioDynamics., Koninklijke Philips N.V., Penumbra, Inc., and others.

Scope of Report

Key Segments Covered in the Thrombectomy System Industry Survey

By Type:

• Hydrodynamic
• Ultrasound
• Aspiration
• Mechanical Thrombectomy

By Application:

• Cardiovascular Application
• Peripheral Vascular Application
• Neurovascular Application

By End User:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa